5146e0df8b
- Source: inbox/queue/2026-04-22-kff-medicare-glp1-bridge-lis-exclusion.md - Domain: health - Claims: 2, Entities: 1 - Enrichments: 2 - Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5) Pentagon-Agent: Vida <PIPELINE>
2.2 KiB
| type | entity_type | name | domain | status | start_date | end_date | parent_organization |
|---|---|---|---|---|---|---|---|
| entity | research_program | Medicare GLP-1 Bridge Program | health | active | 2026-07-01 | 2026-12-31 | Centers for Medicare & Medicaid Services (CMS) |
Medicare GLP-1 Bridge Program
Overview
Temporary Medicare demonstration program providing coverage for GLP-1 receptor agonists (Wegovy, Zepbound) for obesity treatment from July 1 to December 31, 2026. Operates as an exception to Medicare's statutory prohibition on weight-loss drug coverage.
Program Structure
Eligibility:
- BMI ≥35 alone, OR
- BMI ≥27 with clinical criteria
- Must be enrolled in Medicare Part D
Cost-sharing:
- Fixed $50 copayment per prescription
- Copay does NOT count toward Part D deductible
- Copay does NOT count toward $2,100 out-of-pocket cap
- Low-Income Subsidy (LIS) cost-sharing subsidies do NOT apply
Coverage:
- Wegovy (semaglutide)
- Zepbound (tirzepatide)
Structural Issues
LIS Exclusion: The program operates outside standard Part D benefit structures, making the $50 copay invisible to Low-Income Subsidy mechanisms. This structurally excludes the lowest-income Medicare beneficiaries despite nominal eligibility.
Temporary Duration: Six-month program creates coverage cliff. Beneficiaries wanting 2027 continuation must switch Part D plans during open enrollment to plans participating in the BALANCE Model demonstration (launches January 2027).
Eligible Population: Approximately 14 million Medicare beneficiaries had diagnosed overweight/obesity in 2020, representing potential eligible pool.
Legal Architecture
Operates under CMS demonstration authority as temporary exception to Social Security Act Section 1862(a)(1)(A), which prohibits Medicare coverage of drugs for weight loss. This demonstration status explains the segregated benefit structure and LIS incompatibility.
Related Programs
- BALANCE Model (Medicare Part D): Launches January 2027, longer-term demonstration
- BALANCE Model (Medicaid): Launches May 2026
Timeline
- 2026-04 — Program details announced by CMS
- 2026-07-01 — Coverage begins
- 2026-12-31 — Coverage ends
- 2027-01 — BALANCE Model begins (requires plan switching during open enrollment)